Search

Author/Creator Howell, H.

1. INTERIM UPDATE FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA. (12th June 2019)

Authors:
Morschhauser, F.; Tilly, H.; Chaidos, A.; Phillips, T.; Ribrag, V.; Campbell, P.; Ghandi Laurent, D.; Jurczak, W.; McKay, P.; Opat, S.; Radford, J.; Rajarethinam, A.; Yang, J.; Howell, H.; Newberry, K.J.; Adib, D.; Salles, G.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0235 PHASE 1 CLINICAL STUDY OF MGTA-145 IN COMBINATION WITH PLERIXAFOR SHOWS RAPID SINGLE-DAY MOBILISATION AND COLLECTION OF CD34+ HAEMATOPOIETIC STEM CELLS WITHOUT G-CSF. (2nd June 2020)

Authors:
Dipersio, J.; Devine, S.; Hoggatt, J.; Scadden, D.; Howell, H.; Schmelmer, V.; Neale, J.; Boitano, T.; Cooke, M.; Morrow, D.; Raffel, G.; Savage, W.; Goncalves, K.; Falahee, P.; Davis, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
701
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1559: DISC-0974, A FIRST-IN-HUMAN ANTI-HEMOJUVELIN MONOCLONAL ANTIBODY, REDUCES SERUM HEPCIDIN LEVELS AND MOBILIZES IRON IN HEALTHY PARTICIPANTS. (23rd June 2022)

Authors:
Novikov, N.; Yang, H.; Nguyen, S.; Buch, A.; Tuller, S.; Andruk, M.; Chan, K.; Wu, M.; Rodriguez, R.; Panwar, R.; Howell, H.; MacDonald, B.; Savage, W.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗